Capture.JPG
iosBio appoints Patricia Londono-Hayes as Chief Development Officer
June 14, 2021 02:00 ET | iosBio
PRESS RELEASE iosBio appoints Patricia Londono-Hayes as Chief Development Officer Oral vaccines and biotherapeutics company strengthens senior leadership team with new role to drive priority...
iosBio Logo (CMYK).png
iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19  
January 12, 2021 07:00 ET | iosBio
PRESS RELEASE iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19             iosBio licenses its OraProTM...
iosBio Logo (CMYK).png
iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19  
January 12, 2021 02:00 ET | iosBio
PRESS RELEASE iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19             iosBio licenses its OraProTM...
iosBio Logo (CMYK).png
Stabilitech Biopharma announces name change to iosBio
September 30, 2020 02:00 ET | iosBio
PRESS RELEASE Stabilitech Biopharma announces name change to iosBio Burgess Hill, UK, 30 September 2020, STABILITECH BIOPHARMA (the “Company”), a UK-based biotechnology company developing next...